ES2898704T3 - Compuestos de platino funcionalizados con monomaleimida para la terapia del cáncer - Google Patents

Compuestos de platino funcionalizados con monomaleimida para la terapia del cáncer Download PDF

Info

Publication number
ES2898704T3
ES2898704T3 ES16822917T ES16822917T ES2898704T3 ES 2898704 T3 ES2898704 T3 ES 2898704T3 ES 16822917 T ES16822917 T ES 16822917T ES 16822917 T ES16822917 T ES 16822917T ES 2898704 T3 ES2898704 T3 ES 2898704T3
Authority
ES
Spain
Prior art keywords
alkyl
alkylene
cancer
compound
moiety
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES16822917T
Other languages
English (en)
Spanish (es)
Inventor
Christian Kowol
Petra Heffeter
Walter Berger
Bernhard K Keppler
Josef Mayr
Verena Pichler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical University of Vienna
University of Vienna
Original Assignee
Medical University of Vienna
University of Vienna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical University of Vienna, University of Vienna filed Critical Medical University of Vienna
Application granted granted Critical
Publication of ES2898704T3 publication Critical patent/ES2898704T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES16822917T 2015-12-09 2016-12-09 Compuestos de platino funcionalizados con monomaleimida para la terapia del cáncer Active ES2898704T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15198739 2015-12-09
PCT/EP2016/080453 WO2017097986A1 (en) 2015-12-09 2016-12-09 Monomaleimide-functionalized platinum compounds for cancer therapy

Publications (1)

Publication Number Publication Date
ES2898704T3 true ES2898704T3 (es) 2022-03-08

Family

ID=54849106

Family Applications (1)

Application Number Title Priority Date Filing Date
ES16822917T Active ES2898704T3 (es) 2015-12-09 2016-12-09 Compuestos de platino funcionalizados con monomaleimida para la terapia del cáncer

Country Status (21)

Country Link
US (2) US10723748B2 (cg-RX-API-DMAC10.html)
EP (1) EP3386997B1 (cg-RX-API-DMAC10.html)
JP (1) JP6867652B2 (cg-RX-API-DMAC10.html)
CN (1) CN108368143B (cg-RX-API-DMAC10.html)
AU (1) AU2016367306B2 (cg-RX-API-DMAC10.html)
CA (1) CA3004630A1 (cg-RX-API-DMAC10.html)
CY (1) CY1124529T1 (cg-RX-API-DMAC10.html)
DK (1) DK3386997T3 (cg-RX-API-DMAC10.html)
ES (1) ES2898704T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20211466T1 (cg-RX-API-DMAC10.html)
HU (1) HUE056897T2 (cg-RX-API-DMAC10.html)
IL (1) IL259864B (cg-RX-API-DMAC10.html)
LT (1) LT3386997T (cg-RX-API-DMAC10.html)
MX (1) MX377528B (cg-RX-API-DMAC10.html)
PL (1) PL3386997T3 (cg-RX-API-DMAC10.html)
PT (1) PT3386997T (cg-RX-API-DMAC10.html)
RS (1) RS62412B1 (cg-RX-API-DMAC10.html)
SG (1) SG11201804885TA (cg-RX-API-DMAC10.html)
SI (1) SI3386997T1 (cg-RX-API-DMAC10.html)
SM (1) SMT202100709T1 (cg-RX-API-DMAC10.html)
WO (1) WO2017097986A1 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112016030310A2 (pt) * 2014-06-23 2017-08-22 Placon Therapeutics Inc Compostos de platina, composições e seus usos
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
CN109171001A (zh) * 2018-09-14 2019-01-11 上海烟草集团有限责任公司 草酸钠在降低卷烟烟气中TSNAs释放量中的应用
WO2021138215A1 (en) * 2019-12-31 2021-07-08 Kinnate Biopharma Inc. Treatment of cancer with cdk12/13 inhibitors
CN114163479B (zh) * 2020-09-11 2025-05-16 上海海聚生物科技有限公司 一类治疗癌症用的铂类化合物及其制备方法
US20230339997A1 (en) * 2020-09-11 2023-10-26 Shanghai Haiju Biological Technology Co., Ltd. Class of platinum compounds for treating cancer, and method for preparation thereof
CN114539320B (zh) * 2020-11-25 2026-01-27 北京大学 辐射激活的四价铂配合物及其用途
WO2026132589A1 (en) 2024-12-19 2026-06-25 Universität Wien Egfr inhibitor-functionalized albumin-binding platinum compounds for cancer therapy

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
CH605550A5 (cg-RX-API-DMAC10.html) 1972-06-08 1978-09-29 Research Corp
US4263428A (en) 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
DE3169595D1 (en) 1980-11-10 1985-05-02 Gersonde Klaus Method of preparing lipid vesicles by ultrasonic treatment, the use of this method and apparatus for its application
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
EP0088046B1 (de) 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipide in wässriger Phase
DE3218121A1 (de) 1982-05-14 1983-11-17 Leskovar, Peter, Dr.-Ing., 8000 München Arzneimittel zur tumorbehandlung
EP0102324A3 (de) 1982-07-29 1984-11-07 Ciba-Geigy Ag Lipide und Tenside in wässriger Phase
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
JPS607934A (ja) 1983-06-29 1985-01-16 Dai Ichi Seiyaku Co Ltd リポソ−ムの製造方法
HUT35524A (en) 1983-08-02 1985-07-29 Hoechst Ag Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
DE3486459D1 (de) 1983-09-26 1997-12-11 Udo Dr Med Ehrenfeld Mittel und Erzeugnis für die Diagnose und Therapie von Tumoren sowie zur Behandlung von Schwächen der zelligen und humoralen Immunabwehr
EP0143949B1 (en) 1983-11-01 1988-10-12 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Pharmaceutical composition containing urokinase
CS269719B1 (en) 1986-12-29 1990-05-14 Kiss Frantisek Platinum cytostatic
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
DE19636889A1 (de) 1996-09-11 1998-03-12 Felix Dr Kratz Antineoplastisch wirkende Transferrin- und Albuminkonjugate zytostatischer Verbindungen aus der Gruppe der Anthrazykline, Alkylantien, Antimetabolite und Cisplatin-Analoga und diese enthaltende Arzneimittel
ATE248583T1 (de) 1997-09-29 2003-09-15 Nektar Therapeutics In dosierinhalatoren verwendbare, stabilisierte zubereitungen
CA2326389C (en) 1998-04-21 2007-01-23 Micromet Gesellschaft Fur Biomedizinische Forschung Mbh Novel cd19xcd3 specific polypeptides and uses thereof
DE19926154A1 (de) 1999-06-09 2000-12-14 Ktb Tumorforschungs Gmbh Verfahren zur Herstellung einer injizierbaren Arzneimittelzubereitung
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
DE10314780A1 (de) 2003-03-19 2004-09-30 Ktb Tumorforschungsgesellschaft Mbh Proteinbindende Derivate von Platinkomplexen mit Cyclobutan-1,1-dicarboxylatliganden
JP2006521300A (ja) 2003-03-31 2006-09-21 プリヴァ−ラケマ，エー．エス． 活性物質として白金錯体を含有する医薬組成物およびその製造方法
CZ296169B6 (cs) 2004-09-08 2006-01-11 Pliva - Lachema A. S. Farmaceutická kompozice pro rektální nebo vaginální podání, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
CZ2004964A3 (cs) 2004-09-14 2006-03-15 Pliva-Lachema A. S. Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
US20060205810A1 (en) 2004-11-24 2006-09-14 Schering Corporation Platinum therapeutic combinations
CZ300424B6 (cs) 2006-06-20 2009-05-13 Pliva - Lachema A. S. Farmaceutická kompozice pro perorální podání
CZ300120B6 (cs) 2006-06-20 2009-02-11 Pliva - Lachema A. S. Farmaceutická kompozice pro injekcní podání
CZ300590B6 (cs) 2006-06-20 2009-06-24 Pliva - Lachema A. S. Farmaceutická kompozice pro injekcní podání
BR112014013526A8 (pt) 2011-12-05 2017-06-13 Igenica Biotherapeutics Inc conjugados de anticorpo-fármaco e compostos, composições e métodos relacionados
CN104302408B (zh) * 2012-02-27 2016-12-14 阿穆尼克斯运营公司 Xten缀合组合物和制造其的方法
WO2015052516A1 (en) * 2013-10-08 2015-04-16 Atlas Genetics Limited Labelling compounds and their use in assays
EP3089745A4 (en) 2013-12-31 2017-05-17 Placon Therapeutics, Inc. Compounds, compositions, and methods for the treatment of cancers
BR112016030310A2 (pt) * 2014-06-23 2017-08-22 Placon Therapeutics Inc Compostos de platina, composições e seus usos
US10342801B2 (en) 2015-06-23 2019-07-09 Placon Therapeutics, Inc. Platinum compounds, compositions, and uses thereof
US20180186823A1 (en) 2015-06-23 2018-07-05 Placon Therapeutics, Inc. Platinum compounds, compositions, and uses thereof
WO2017004123A1 (en) 2015-06-29 2017-01-05 Case Western Reserve University Anticancer drug-containing plant virus particles
CA2991973C (en) 2015-07-12 2021-12-07 Suzhou M-Conj Biotech Co., Ltd. Bridge linkers for conjugation of a cell-binding molecule
JP7043425B2 (ja) 2016-06-06 2022-03-29 ジェネンテック， インコーポレイテッド シルベストロール抗体－薬物コンジュゲート及び使用方法
JP2019524706A (ja) 2016-07-08 2019-09-05 ジェネンテック， インコーポレイテッド Ｍｕｃ１６陽性癌治療の応答性を評価するためのヒト精巣上体タンパク質４（ｈｅ４）の使用
WO2018026742A1 (en) 2016-08-01 2018-02-08 Askgene Pharma Inc. Novel antibody-albumin-drug conjugates (aadc) and methods for using them
CN108164512B (zh) 2017-12-27 2021-05-25 沈阳药科大学 一类具有生物粘附作用的马来酰亚胺型前药及其在口服药物传递中的应用
CN108187063B (zh) 2018-01-09 2020-09-08 沈阳药科大学 白蛋白结合型抗肿瘤药-马来酰亚胺分子前药

Also Published As

Publication number Publication date
SI3386997T1 (sl) 2021-11-30
LT3386997T (lt) 2021-12-10
PL3386997T3 (pl) 2021-12-13
HUE056897T2 (hu) 2022-03-28
AU2016367306A1 (en) 2018-06-14
MX377528B (es) 2025-03-10
HRP20211466T1 (hr) 2021-12-24
AU2016367306B2 (en) 2021-04-22
US20180354979A1 (en) 2018-12-13
SMT202100709T1 (it) 2022-01-10
CN108368143A (zh) 2018-08-03
JP6867652B2 (ja) 2021-05-12
IL259864A (en) 2018-07-31
US11572379B2 (en) 2023-02-07
DK3386997T3 (da) 2021-09-20
EP3386997A1 (en) 2018-10-17
IL259864B (en) 2022-07-01
EP3386997B1 (en) 2021-06-30
US20210002313A1 (en) 2021-01-07
MX2018006953A (es) 2019-05-16
RS62412B1 (sr) 2021-10-29
CN108368143B (zh) 2022-02-01
US10723748B2 (en) 2020-07-28
SG11201804885TA (en) 2018-07-30
CA3004630A1 (en) 2017-06-15
JP2018538292A (ja) 2018-12-27
PT3386997T (pt) 2021-11-04
CY1124529T1 (el) 2022-07-22
WO2017097986A1 (en) 2017-06-15

Similar Documents

Publication Publication Date Title
US11572379B2 (en) Monomaleimide-functionalized platinum compounds for cancer therapy
KR101915452B1 (ko) 백금 화합물, 조성물 및 이의 용도
JP2020518673A (ja) 二官能性キレートの薬物動態増強及びその使用
AU2014239254B2 (en) Crystalline forms of tyrosine kinase inhibitors and their salts
US8980933B2 (en) Combretastatin analogs for use in the treatment of cancer
JP6532515B2 (ja) 新規な含窒素化合物もしくはその塩またはそれらと金属との錯体
CN116710437A (zh) 配体及其用途
CN114728934A (zh) 杂环衍生物、药物组合物和它们治疗或改善癌症的用途
CN106232581A (zh) 用于靶向化疗的非铂基抗癌化合物
AU2020361679B2 (en) Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy
AU2022246090B2 (en) Enamine n-oxides: synthesis and application to hypoxia-responsive prodrugs and imaging agents
EP3560497A1 (en) Compositions and methods for drug-sensitization or inhibition of a cancer cell
JP2019514969A (ja) 分子イメージング及びがんの免疫療法のためのδオピオイド受容体標的化薬
WO2016135138A1 (en) Oxoquinoline derivatives as mth1 inhibitors for the therapy of cancer
WO2020198742A1 (en) High-affinity cu(i) ligands and methods of use thereof
WO2016135140A1 (en) 4-aminoquinazoline derivatives as mth1 inhibitors for the therapy of cancer
EA047198B1 (ru) Конъюгаты фосфолипид-флаваглин и способы их применения для нацеленной противораковой терапии
WO2025193796A1 (en) Ros-activatable prodrugs of doxazolidine as novel cancer therapy paradigm
HK40099290A (en) Ligands and their use
HK40031591B (en) Markers, conjugates, compositions and methods for hypoxia imaging, mapping, and therapy